SNPS stock forecast, quote, news & analysis

Key Takeaways

• Synopsys shares fell approximately 17.8% over the last 30 days, dropping from $454.34 on June 26 to $373.47 by July 24, amid a confluence of company-specific and broader market headwinds.
• A May 27 earnings beat-and-raise paradoxically fueled the selloff, as investors interpreted restrained full-year guidance and decelerating IP licensing growth as cautionary signals.
• The company's July decision to sunset legacy manufacturing process-control software, while strategically refocusing on AI-driven design tools, introduced near-term uncertainty among major chipmaker clients.
• A broad semiconductor selloff on July 17 accelerated losses, with SNPS shedding 7.9% in a single session alongside a 2.2% Nasdaq decline.
• Analyst consensus remains a "Moderate Buy" with an average price target of approximately $570, implying significant upside from current levels, though technical indicators signal deeply oversold conditions.
• Over the broader quarter, the stock has retreated markedly from the mid-$490s range as the market continues to reassess Synopsys' post-Ansys acquisition growth and margin trajectory.

Synopsys (SNPS) Company Overview and Market Position

Synopsys, Inc. is a dominant provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify, and manufacture integrated circuits and complex systems-on-chip (SoCs). Its tools enable chipmakers to simulate, synthesize, and validate increasingly complex architectures before production begins. The company occupies a near-duopoly position in EDA alongside Cadence Design Systems, with deep integration into customer workflows that create substantial switching costs. The completed $35 billion acquisition of Ansys in late 2024 expanded Synopsys' reach into multiphysics simulation spanning structural, fluid, thermal, and electromagnetic analysis, broadening its addressable market well beyond chip design into automotive, aerospace, and industrial applications. With a market capitalization of approximately $71.5 billion and institutional ownership exceeding 85%, Synopsys is closely watched by investors as a bellwether for semiconductor R&D spending and AI infrastructure demand.

Synopsys (SNPS) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 calendar days, SNPS declined from a closing price of $454.34 on June 26 to $373.47 on July 24, representing a decline of approximately 17.8%. The descent was not gradual; the stock experienced an accelerating selloff through mid-July, punctuated by a 7.9% single-day plunge on July 17 when shares dropped from $417.03 to $384.24. By late July, SNPS was trading roughly 41% below its 52-week high of $651.73 reached in July 2025, with the Relative Strength Index falling to deeply oversold territory near 22.5.

The quarterly picture is similarly stark. From trading around the $495–$500 range in late May following the company's fiscal Q2 earnings release, the stock has steadily deteriorated. The 50-day moving average sits at approximately $456, while the 200-day moving average hovers near $455 — both significantly above the current trading price, indicating sustained technical weakness. The stock's trajectory over the quarter reflects a market that has progressively repriced Synopsys as integration costs, margin concerns, and strategic repositioning have weighed on investor conviction.

What Drove SNPS Stock Price in the Last 30 Days

Multiple catalysts converged to drive Synopsys lower over the past month. The most significant originated with the company's fiscal Q2 2026 earnings report on May 27, where revenue of $2.28 billion and non-GAAP EPS of $3.35 both exceeded consensus estimates. Despite the headline beat, management's decision to raise full-year guidance only to roughly the midpoint of analyst expectations — rather than delivering a more aggressive upward revision — was interpreted as a signal of caution around second-half demand. Investors zeroed in on decelerating growth in the high-margin IP licensing business, which carries disproportionate weight in Synopsys' profitability profile.

In early July, Reuters reported that Synopsys had informed over a dozen major semiconductor manufacturers — including Samsung Electronics, SK Hynix, Kioxia, and Qorvo — that it would discontinue a portfolio of legacy manufacturing process-control software products. While the company framed this as a strategic reallocation toward higher-margin AI-driven design tools, the announcement introduced near-term execution uncertainty and raised questions about potential revenue disruption.

A broad-based semiconductor selloff on July 17 compounded the pressure, with the Nasdaq falling 2.22% as investors rotated out of concentrated AI and technology positions. SNPS was caught in the downdraft, shedding nearly 8% in a single session. Insider selling also drew attention: CFO Shelagh Glaser sold shares at $450.02 on June 12, and CEO Sassine Ghazi sold shares at $458.96 on June 15, both under pre-arranged Rule 10b5-1 trading plans. While such sales are routine, they occurred at prices substantially above where the stock currently trades. Meanwhile, institutional activity was mixed — Dimensional Fund Advisors boosted its position by 28.1%, while Harel Insurance Investments cut its stake by 99.6%.

On the positive side, Benchmark initiated coverage with a Buy rating and a $570 price target on July 15, and Goldman Sachs highlighted Synopsys as a key beneficiary of the structural chip-design engineer shortage with a $600 price target. However, these bullish calls were insufficient to counter the overwhelming selling pressure.

What Drove SNPS Stock Performance Over the Last Quarter

The broader quarterly decline reflects a market that has grown more cautious about Synopsys' post-Ansys integration trajectory. While the acquisition substantially expanded the company's total addressable market and delivered eye-catching revenue growth of approximately 42% year-over-year, reported GAAP profitability has been compressed by integration costs, amortization of acquired intangibles, and deal-related charges. GAAP net income for Q2 was just $17.1 million, versus $349.2 million a year earlier, while GAAP EPS of $0.09 contrasted sharply with the non-GAAP figure of $3.35. This wide gap between GAAP and non-GAAP results has fueled debate about the true earnings power of the combined entity.

Additionally, management's commentary around "agentic AI" — AI systems that run Synopsys software alongside human engineers — signals a potentially transformative but unproven pricing model shift. CEO Sassine Ghazi described at the Mizuho Technology Conference a future where the company charges not just for human user subscriptions but for AI agent usage as well. While strategically compelling, this transition introduces complexity into revenue visibility at a time when investors are demanding clearer evidence that the Ansys deal will deliver the promised cross-selling synergies and margin expansion. The upcoming Investor Day on September 30 is widely expected to provide more clarity on these long-term targets.

Trending AI Robots

As traders navigate volatile periods in stocks like Synopsys, many are turning to automated strategies for data-driven decision-making. Tickeron's Trending AI Robots page offers a curated view of the platform's top-performing AI-powered trading bots, selected from hundreds of bots actively trading thousands of tickers across global markets. Each bot operates with a distinct strategy, timeframe, and set of performance metrics — ranging from short-term momentum models to longer-term trend-following approaches — giving users the opportunity to explore automated trading solutions that match their objectives. Only bots demonstrating consistent relevance and strong recent performance appear in this featured section, making it a useful starting point for investors curious about the intersection of artificial intelligence and active portfolio management.

SNPS Stock Forecast Drivers: What Investors Should Watch Next

Investors will be closely monitoring Synopsys' fiscal Q3 2026 earnings, expected in late August, for evidence that the IP licensing business is stabilizing and that full-year guidance can be revised materially higher. The company's September 30 Investor Day represents a critical catalyst, where management is expected to lay out long-term financial targets and elaborate on the AI-agent pricing model and Ansys synergy roadmap. Macroeconomic risks remain salient, including potential changes to U.S. export controls affecting China-exposed revenue (approximately 10% of total sales), geopolitical instability, and the trajectory of semiconductor R&D budgets in an environment of elevated trade tensions. On the competitive front, the duopoly with Cadence Design Systems remains stable, but the growing trend of hyperscale customers building custom chips in-house could reshape demand patterns over time. Technical traders will be watching whether deeply oversold RSI readings near 22 translate into a mean-reversion rally or whether structural concerns continue to drive price discovery lower.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.